124 related articles for article (PubMed ID: 34896245)
41. Sensitivity of chronic lymphocytic leukemia cells to chemotherapeutic drugs ex vivo depends on expression status of cell surface receptors.
Shcherbina V; Gordiienko I; Shlapatska L; Ivanivska T; Sidorenko S
Exp Oncol; 2020 Mar; 42(1):16-24. PubMed ID: 32231196
[TBL] [Abstract][Full Text] [Related]
42. OSU-T315: a novel targeted therapeutic that antagonizes AKT membrane localization and activation of chronic lymphocytic leukemia cells.
Liu TM; Ling Y; Woyach JA; Beckwith K; Yeh YY; Hertlein E; Zhang X; Lehman A; Awan F; Jones JA; Andritsos LA; Maddocks K; MacMurray J; Salunke SB; Chen CS; Phelps MA; Byrd JC; Johnson AJ
Blood; 2015 Jan; 125(2):284-95. PubMed ID: 25293770
[TBL] [Abstract][Full Text] [Related]
43. Enhanced levels of both the membrane-bound and soluble forms of IgM Fc receptor (FcμR) in patients with chronic lymphocytic leukemia.
Li FJ; Kubagawa Y; McCollum MK; Wilson L; Motohashi T; Bertoli LF; Barton JC; Barnes S; Davis RS; Kubagawa H
Blood; 2011 Nov; 118(18):4902-9. PubMed ID: 21908424
[TBL] [Abstract][Full Text] [Related]
44. Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia.
Bojarska-Junak A; Rolinski J; Wasik-Szczepaneko E; Kaluzny Z; Dmoszynska A
Haematologica; 2002 May; 87(5):490-9. PubMed ID: 12010662
[TBL] [Abstract][Full Text] [Related]
45. Do biologic parameters affect the time to first treatment of clinical monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Rai stage 0? Results of a prospective analysis.
Molica S; Giannarelli D; Levato L; Gentile M; Mirabelli R; Morabito F
Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):e55-60. PubMed ID: 25445470
[TBL] [Abstract][Full Text] [Related]
46. Resistance to Dasatinib in primary chronic lymphocytic leukemia lymphocytes involves AMPK-mediated energetic re-programming.
Martinez Marignac VL; Smith S; Toban N; Bazile M; Aloyz R
Oncotarget; 2013 Dec; 4(12):2550-66. PubMed ID: 24334291
[TBL] [Abstract][Full Text] [Related]
47. Laboratory, morphologic, and immunophenotypic correlates of surface immunoglobulin heavy chain isotype expression in B-cell chronic lymphocytic leukemia.
Shen PU; Fuller SG; Rezuke WN; Sherburne BJ; DiGiuseppe JA
Am J Clin Pathol; 2001 Dec; 116(6):905-12. PubMed ID: 11764081
[TBL] [Abstract][Full Text] [Related]
48. PD-1 Expression in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Large B-cell Richter Transformation (DLBCL-RT): A Characteristic Feature of DLBCL-RT and Potential Surrogate Marker for Clonal Relatedness.
He R; Ding W; Viswanatha DS; Chen D; Shi M; Van Dyke D; Tian S; Dao LN; Parikh SA; Shanafelt TD; Call TG; Ansell SM; Leis JF; Mai M; Hanson CA; Rech KL
Am J Surg Pathol; 2018 Jul; 42(7):843-854. PubMed ID: 29762141
[TBL] [Abstract][Full Text] [Related]
49. Dichotomy in NF-kappaB signaling and chemoresistance in immunoglobulin variable heavy-chain-mutated versus unmutated CLL cells upon CD40/TLR9 triggering.
Tromp JM; Tonino SH; Elias JA; Jaspers A; Luijks DM; Kater AP; van Lier RA; van Oers MH; Eldering E
Oncogene; 2010 Sep; 29(36):5071-82. PubMed ID: 20581863
[TBL] [Abstract][Full Text] [Related]
50. Preferential use of unmutated immunoglobulin heavy variable region genes in Boxer dogs with chronic lymphocytic leukemia.
Rout ED; Burnett RC; Labadie JD; Yoshimoto JA; Avery AC
PLoS One; 2018; 13(1):e0191205. PubMed ID: 29385200
[TBL] [Abstract][Full Text] [Related]
51. Metabolic rewiring beyond Warburg in chronic lymphocytic leukemia: How much do we actually know?
Galicia-Vázquez G; Aloyz R
Crit Rev Oncol Hematol; 2019 Feb; 134():65-70. PubMed ID: 30771875
[TBL] [Abstract][Full Text] [Related]
52. FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemia.
Li FJ; Ding S; Pan J; Shakhmatov MA; Kashentseva E; Wu J; Li Y; Soong SJ; Chiorazzi N; Davis RS
Blood; 2008 Jul; 112(1):179-87. PubMed ID: 18314442
[TBL] [Abstract][Full Text] [Related]
53. Targeting lipid metabolism by the lipoprotein lipase inhibitor orlistat results in apoptosis of B-cell chronic lymphocytic leukemia cells.
Pallasch CP; Schwamb J; Königs S; Schulz A; Debey S; Kofler D; Schultze JL; Hallek M; Ultsch A; Wendtner CM
Leukemia; 2008 Mar; 22(3):585-92. PubMed ID: 18079738
[TBL] [Abstract][Full Text] [Related]
54. Activity of the notch-signalling pathway in circulating human chronic lymphocytic leukaemia cells.
Hajdu M; Sebestyén A; Barna G; Reiniger L; Jánosi J; Sréter L; Várkonyi J; Demeter J; Kopper L
Scand J Immunol; 2007 Mar; 65(3):271-5. PubMed ID: 17309782
[TBL] [Abstract][Full Text] [Related]
55. IGHV3-21 gene usage is associated with high TCL1 expression in chronic lymphocytic leukemia.
Mansouri MR; Sevov M; Aleskog A; Jondal M; Merup M; Sundström C; Osorio L; Rosenquist R
Eur J Haematol; 2010 Feb; 84(2):109-16. PubMed ID: 19889012
[TBL] [Abstract][Full Text] [Related]
56. [Expression of stereotyped B-cell receptor and its clinical value in chronic lymphocytic leukemia].
Yu Z; Li ZJ; Yi SH; Zhou KS; Hao M; Li CH; Qi JY; Qiu LG
Zhonghua Yi Xue Za Zhi; 2011 Dec; 91(46):3267-70. PubMed ID: 22333147
[TBL] [Abstract][Full Text] [Related]
57. T-cell independent, B-cell receptor-mediated induction of telomerase activity differs among IGHV mutation-based subgroups of chronic lymphocytic leukemia patients.
Damle RN; Temburni S; Banapour T; Paul S; Mongini PK; Allen SL; Kolitz JE; Rai KR; Chiorazzi N
Blood; 2012 Sep; 120(12):2438-49. PubMed ID: 22875913
[TBL] [Abstract][Full Text] [Related]
58. Stereotyped subset #1 chronic lymphocytic leukemia: a direct link between B-cell receptor structure, function, and patients' prognosis.
Del Giudice I; Chiaretti S; Santangelo S; Tavolaro S; Peragine N; Marinelli M; Ilari C; Raponi S; Messina M; Nanni M; Mauro FR; Piciocchi A; Bontempi K; Rossi D; Gaidano G; Guarini A; Foà R
Am J Hematol; 2014 Jan; 89(1):74-82. PubMed ID: 24030933
[TBL] [Abstract][Full Text] [Related]
59. Immunohistochemical analysis of ZAP-70 expression in B-cell lymphoid neoplasms.
Carreras J; Villamor N; Colomo L; Moreno C; Ramón y Cajal S; Crespo M; Tort F; Bosch F; López-Guillermo A; Colomer D; Montserrat E; Campo E
J Pathol; 2005 Mar; 205(4):507-13. PubMed ID: 15685592
[TBL] [Abstract][Full Text] [Related]
60. The meaning and relevance of B-cell receptor structure and function in chronic lymphocytic leukemia.
Stevenson FK; Forconi F; Packham G
Semin Hematol; 2014 Jul; 51(3):158-67. PubMed ID: 25048780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
